Operating Expenses Summary of Biotron Limited

Biotron Limited's latest annual operating expenses in 2024 was 5.11 Million AUD , up 2.31% from previous year.
Biotron Limited's latest quarterly operating expenses in 2024 FY was 5.11 Million AUD , up 2.31% from previous quarter.
Biotron Limited reported a annual operating expenses of 4.99 Million AUD in annual operating expenses 2023, up 82.72% from previous year.
Biotron Limited reported a annual operating expenses of 2.73 Million AUD in annual operating expenses 2022, down -35.97% from previous year.
Biotron Limited reported a quarterly operating expenses of 5.11 Million AUD for 2024 FY, up 2.31% from previous quarter.
Biotron Limited reported a quarterly operating expenses of 2.11 Million AUD for 2024 Q4, down 0.0% from previous quarter.

Annual Operating Expenses Chart of Biotron Limited (2024 - 2000)

Historical Annual Operating Expenses of Biotron Limited (2024 - 2000)

Year	Operating Expenses	Operating Expenses Growth
2024	5.11 Million AUD	2.31%
2023	4.99 Million AUD	82.72%
2022	2.73 Million AUD	-35.97%
2021	4.26 Million AUD	6.78%
2020	3.99 Million AUD	44.8%
2019	2.76 Million AUD	-14.59%
2018	3.23 Million AUD	-26.25%
2017	4.38 Million AUD	1.76%
2016	4.3 Million AUD	-3.06%
2015	4.44 Million AUD	-8.92%
2014	4.87 Million AUD	-1.54%
2013	4.95 Million AUD	60.16%
2012	3.09 Million AUD	27.76%
2011	2.42 Million AUD	26.42%
2010	1.91 Million AUD	4.09%
2009	1.84 Million AUD	-22.97%
2008	2.38 Million AUD	-37.02%
2007	3.79 Million AUD	22.58%
2006	3.09 Million AUD	17.29%
2005	2.63 Million AUD	-24.91%
2004	3.51 Million AUD	32.36%
2003	2.65 Million AUD	39.82%
2002	1.89 Million AUD	22.76%
2001	1.54 Million AUD	0.0%
2000	- AUD	0.0%

Year	Operating Expenses	Operating Expenses Growth
2024 Q2	2.94 Million AUD	0.0%
2024 FY	5.11 Million AUD	2.31%
2024 Q4	2.11 Million AUD	0.0%
2023 FY	4.99 Million AUD	82.72%
2023 Q2	2.14 Million AUD	0.0%
2023 Q4	2.76 Million AUD	0.0%
2022 Q2	1.87 Million AUD	0.0%
2022 FY	2.73 Million AUD	-35.97%
2022 Q4	818.81 Thousand AUD	0.0%
2021 Q4	2.18 Million AUD	0.0%
2021 Q2	2.4 Million AUD	0.0%
2021 FY	4.26 Million AUD	6.78%
2020 Q4	2.3 Million AUD	0.0%
2020 Q2	2.04 Million AUD	0.0%
2020 FY	3.99 Million AUD	44.8%
2019 Q4	1.41 Million AUD	0.0%
2019 FY	2.76 Million AUD	-14.59%
2019 Q2	1.35 Million AUD	0.0%
2018 Q2	1.79 Million AUD	0.0%
2018 Q4	1.44 Million AUD	0.0%
2018 FY	3.23 Million AUD	-26.25%
2017 Q2	2.02 Million AUD	0.0%
2017 FY	4.38 Million AUD	1.76%
2017 Q4	2.75 Million AUD	0.0%
2016 Q2	2.81 Million AUD	0.0%
2016 Q4	1.81 Million AUD	0.0%
2016 FY	4.3 Million AUD	-3.06%
2015 Q4	2.24 Million AUD	0.0%
2015 FY	4.44 Million AUD	-8.92%
2015 Q2	2.2 Million AUD	0.0%
2014 Q4	2.22 Million AUD	0.0%
2014 Q2	2.65 Million AUD	0.0%
2014 FY	4.87 Million AUD	-1.54%
2013 Q3	78.95 Thousand AUD	-96.79%
2013 FY	4.95 Million AUD	60.16%
2013 Q2	2.45 Million AUD	3356.2%
2013 Q1	71.11 Thousand AUD	0.0%
2013 Q4	2.49 Million AUD	3062.11%
2012 Q1	71.57 Thousand AUD	0.0%
2012 Q2	71.11 Thousand AUD	-0.64%
2012 Q4	71.11 Thousand AUD	0.0%
2012 FY	3.09 Million AUD	27.76%
2012 Q3	71.11 Thousand AUD	0.0%
2011 FY	2.42 Million AUD	26.42%
2011 Q4	71.57 Thousand AUD	0.0%
2011 Q1	73.01 Thousand AUD	0.0%
2011 Q2	71.57 Thousand AUD	-1.98%
2011 Q3	71.57 Thousand AUD	0.0%
2010 Q1	56.98 Thousand AUD	0.0%
2010 FY	1.91 Million AUD	4.09%
2010 Q4	73.01 Thousand AUD	0.0%
2010 Q3	73.01 Thousand AUD	0.0%
2010 Q2	73.01 Thousand AUD	28.13%
2009 Q4	56.98 Thousand AUD	0.0%
2009 Q1	63.26 Thousand AUD	0.0%
2009 Q2	56.98 Thousand AUD	-9.93%
2009 Q3	56.98 Thousand AUD	0.0%
2009 FY	1.84 Million AUD	-22.97%
2008 FY	2.38 Million AUD	-37.02%
2008 Q4	63.26 Thousand AUD	0.0%
2008 Q1	113.86 Thousand AUD	0.0%
2008 Q2	63.26 Thousand AUD	-44.44%
2008 Q3	63.26 Thousand AUD	0.0%
2007 Q1	66.28 Thousand AUD	0.0%
2007 Q4	113.86 Thousand AUD	0.0%
2007 FY	3.79 Million AUD	22.58%
2007 Q2	113.86 Thousand AUD	71.78%
2007 Q3	113.86 Thousand AUD	0.0%
2006 Q1	59.64 Thousand AUD	0.0%
2006 Q4	66.28 Thousand AUD	0.0%
2006 Q3	66.28 Thousand AUD	0.0%
2006 Q2	66.28 Thousand AUD	11.14%
2006 FY	3.09 Million AUD	17.29%
2005 Q2	59.64 Thousand AUD	1.74%
2005 FY	2.63 Million AUD	-24.91%
2005 Q3	59.64 Thousand AUD	0.0%
2005 Q1	58.62 Thousand AUD	0.0%
2005 Q4	59.64 Thousand AUD	0.0%
2004 Q2	58.62 Thousand AUD	-26.13%
2004 Q4	58.62 Thousand AUD	0.0%
2004 Q1	79.35 Thousand AUD	0.0%
2004 FY	3.51 Million AUD	32.36%
2004 Q3	58.62 Thousand AUD	0.0%
2003 Q2	79.35 Thousand AUD	-84.68%
2003 FY	2.65 Million AUD	39.82%
2003 Q3	79.35 Thousand AUD	0.0%
2003 Q1	517.96 Thousand AUD	0.0%
2003 Q4	79.35 Thousand AUD	0.0%
2002 FY	1.89 Million AUD	22.76%
2002 Q1	137.6 Thousand AUD	0.0%
2002 Q3	517.96 Thousand AUD	0.0%
2002 Q2	517.96 Thousand AUD	276.43%
2002 Q4	517.96 Thousand AUD	0.0%
2001 Q2	137.6 Thousand AUD	0.0%
2001 Q1	- AUD	0.0%
2001 FY	1.54 Million AUD	0.0%
2001 Q4	137.6 Thousand AUD	0.0%
2001 Q3	137.6 Thousand AUD	0.0%
2000 FY	- AUD	0.0%
2000 Q3	- AUD	0.0%
2000 Q2	- AUD	0.0%
2000 Q4	- AUD	0.0%

Peer Operating Expenses Comparison of Biotron Limited

Name	Operating Expenses	Operating Expenses Difference
AdAlta Limited	6.76 Million AUD	24.504%
Acrux Limited	8.55 Million AUD	40.226%
Botanix Pharmaceuticals Limited	601.82 Thousand AUD	-749.203%
BTC Health Limited	-1.03 Million AUD	591.919%
Chimeric Therapeutics Limited	19.76 Million AUD	74.146%
Clarity Pharmaceuticals Ltd	56.3 Million AUD	90.924%
Clinuvel Pharmaceuticals Limited	31.29 Million AUD	83.67%
Biome Australia Limited	7.91 Million AUD	35.4%
Hexima Limited	1 Million AUD	-406.634%
Immutep Limited	42.87 Million AUD	88.08%
Memphasys Limited	3.67 Million AUD	-38.938%
Neuren Pharmaceuticals Limited	32.69 Million AUD	84.37%
Noxopharm Limited	7 Million AUD	26.992%
Prescient Therapeutics Limited	10.89 Million AUD	53.108%
Race Oncology Limited	14.77 Million AUD	65.399%
Radiopharm Theranostics Limited	299.22 Thousand AUD	-1607.953%
Starpharma Holdings Limited	22.81 Million AUD	77.6%
Tissue Repair Ltd	6.66 Million AUD	23.342%
Alterity Therapeutics Limited	23.4 Million AUD	78.166%
CSL Limited	7.56 Billion AUD	99.932%
EZZ Life Science Holdings Limited	39.57 Million AUD	87.086%
Anatara Lifesciences Ltd	710.21 Thousand AUD	-619.593%
Bio-Gene Technology Limited	2.76 Million AUD	-85.101%
Zelira Therapeutics Limited	5.94 Million AUD	14.085%
Patrys Limited	4.93 Million AUD	-3.595%
Orthocell Limited	15.36 Million AUD	66.748%
Imugene Limited	135.09 Million AUD	96.217%
PYC Therapeutics Limited	60.91 Million AUD	91.61%
Proteomics International Laboratories Limited	892.14 Thousand AUD	-472.854%
Cynata Therapeutics Limited	11.12 Million AUD	54.055%
Arovella Therapeutics Limited	10.78 Million AUD	52.614%
Nanollose Limited	12.5 Thousand AUD	-40782.129%
Invex Therapeutics Ltd	3.34 Million AUD	-52.745%
NeuroScientific Biopharmaceuticals Limited	1.96 Million AUD	-160.056%
Amplia Therapeutics Limited	8.43 Million AUD	39.416%
Island Pharmaceuticals Limited	4.12 Million AUD	-23.884%
Nyrada Inc.	4.55 Million AUD	-12.195%
Telix Pharmaceuticals Limited	269.26 Million AUD	98.102%
Dimerix Limited	25.64 Million AUD	80.07%
PharmAust Limited	6.65 Million AUD	23.228%
AnteoTech Limited	12.18 Million AUD	58.065%
Paradigm Biopharmaceuticals Limited	65.1 Million AUD	92.15%
Recce Pharmaceuticals Ltd	21.68 Million AUD	76.432%
Avecho Biotechnology Limited	4.54 Million AUD	-12.436%
Actinogen Medical Limited	22.77 Million AUD	77.556%
Immuron Limited	9.13 Million AUD	44.072%
Argenica Therapeutics Limited	8.26 Million AUD	38.196%

Global Stocks Search

Biotron Limited (BIT.AX)

Operating Expenses Summary of Biotron Limited

Annual Operating Expenses Chart of Biotron Limited (2024 - 2000)

Historical Annual Operating Expenses of Biotron Limited (2024 - 2000)

Peer Operating Expenses Comparison of Biotron Limited